158 related articles for article (PubMed ID: 9247891)
1. Cure or control of HIV/AIDS?
Collins DO; Sakamoto A
Med Hypotheses; 1997 Jun; 48(6):489-90. PubMed ID: 9247891
[No Abstract] [Full Text] [Related]
2. [HIV: to administer protease inhibitors early].
Dtsch Med Wochenschr; 1996 Dec; 121(49):A49. PubMed ID: 8998916
[No Abstract] [Full Text] [Related]
3. Antiretroviral therapy: a guide to the most important trials.
Rutschmann O; Hirschel B
Schweiz Med Wochenschr; 1997 Mar; 127(11):436-43. PubMed ID: 9098917
[TBL] [Abstract][Full Text] [Related]
4. Nipping HIV in the bud.
Smart T
GMHC Treat Issues; 1996 Aug; 10(8):3-6. PubMed ID: 11363719
[TBL] [Abstract][Full Text] [Related]
5. Incidence and predictors of virologic failure of antiretroviral triple-drug therapy in a community-based cohort.
Paris D; Ledergerber B; Weber R; Jost J; Flepp M; Opravil M; Ruef C; Zimmerli S
AIDS Res Hum Retroviruses; 1999 Dec; 15(18):1631-8. PubMed ID: 10606086
[TBL] [Abstract][Full Text] [Related]
6. [Meeting of the Pediatric Work Group AIDS in Germany (PAAD) on May 8-9, 1998 in Frankfurt/Main].
Funk M
Klin Padiatr; 1999; 211(2):96-7. PubMed ID: 10407820
[No Abstract] [Full Text] [Related]
7. A randomized study comparing triple versus double antiretroviral therapy or no treatment in HIV-1-infected patients in very early stage disease: the Spanish Earth-1 study.
García F; Romeu J; Grau I; Sambeat MA; Dalmau D; Knobel H; Gomez-Sirvent JL; Arrizabalaga J; Cruceta A; Clotet BG; Podzamczer D; Pumarola T; Gallart T; O'Brien WA; Miró JM; Gatell JM
AIDS; 1999 Dec; 13(17):2377-88. PubMed ID: 10597779
[TBL] [Abstract][Full Text] [Related]
8. Crixivan reduces viral load.
AIDS Patient Care STDS; 1996 Feb; 10(1):50. PubMed ID: 11361665
[No Abstract] [Full Text] [Related]
9. A patient's guide to protease inhibitors.
Elperin A; Sax P
AIDS Clin Care; 1996 Oct; 8(10):83-4. PubMed ID: 11363988
[TBL] [Abstract][Full Text] [Related]
10. Contraindicated antiretroviral drug combinations.
Macher A; Thomas D; Paul SM
N J Med; 2003 Sep; 100(9 Suppl):41-3; quiz 73-4. PubMed ID: 14556602
[TBL] [Abstract][Full Text] [Related]
11. Protease inhibitors and prevention of cross resistance.
Levin J
AIDS Treat News; 1995 Oct; (no 232):1-3. PubMed ID: 11362875
[TBL] [Abstract][Full Text] [Related]
12. Safety and efficacy of two different triple drug combinations in which either lamivudine or didanosine were administered with stavudine plus indinavir.
Villalba N; Gómez-Cano M; Casas E; Soriano V; Valencia E; González-Lahoz J
AIDS; 1997 Dec; 11(15):1896-7. PubMed ID: 9412717
[No Abstract] [Full Text] [Related]
13. Guide to major clinical trials of antiretroviral therapy administered to patients infected with human immunodeficiency virus.
Spooner KM; Lane HC; Masur H
Clin Infect Dis; 1996 Jul; 23(1):15-27. PubMed ID: 8816123
[No Abstract] [Full Text] [Related]
14. [Nevirapine: a new principle of action against HIV].
Dtsch Med Wochenschr; 1996 Dec; 121(49):A48-9. PubMed ID: 8998915
[No Abstract] [Full Text] [Related]
15. Zidovudine, didanosine, and zalcitabine in the treatment of HIV infection: meta-analyses of the randomised evidence. HIV Trialists' Collaborative Group.
Lancet; 1999 Jun; 353(9169):2014-25. PubMed ID: 10376616
[TBL] [Abstract][Full Text] [Related]
16. Antiviral effect of AZT versus stavudine in combination with lamivudine and indinavir in the context of a populational study.
Jahnke N; Yip B; Hogg RS; O'Shaughnessy M; Montaner JS
J Acquir Immune Defic Syndr; 1999 Aug; 21(4):347-8. PubMed ID: 10428115
[No Abstract] [Full Text] [Related]
17. Stavudine, lamivudine and indinavir in children with advanced HIV-1 infection: preliminary experience.
Monpoux F; Sirvent N; Cottalorda J; Mariani R; Lefbvre JC
AIDS; 1997 Oct; 11(12):1523-5. PubMed ID: 9342078
[No Abstract] [Full Text] [Related]
18. Resistance mutations to zidovudine and saquinavir in patients receiving zidovudine plus saquinavir or zidovudine and zalcitabine plus saquinavir in AIDS clinical trials group 229.
Schapiro JM; Lawrence J; Speck R; Winters MA; Efron B; Coombs RW; Collier AC; Merigan TC
J Infect Dis; 1999 Jan; 179(1):249-53. PubMed ID: 9841849
[TBL] [Abstract][Full Text] [Related]
19. Relevance of AIDS treatment with two nucleoside analogues alone.
Weidle PJ; Mbidde E; Djomand G; Lackritz EM
Lancet; 1999 Jun; 353(9169):1989-90. PubMed ID: 10376610
[No Abstract] [Full Text] [Related]
20. Low efficacy and high frequency of adverse events in a randomized trial of the triple nucleoside regimen abacavir, stavudine and didanosine.
Gerstoft J; Kirk O; Obel N; Pedersen C; Mathiesen L; Nielsen H; Katzenstein TL; Lundgren JD
AIDS; 2003 Sep; 17(14):2045-52. PubMed ID: 14502007
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
